178 related articles for article (PubMed ID: 17854487)
1. Interactions between the adducin 2 gene and antihypertensive drug therapies in determining blood pressure in people with hypertension.
Kardia SL; Sun YV; Hamon SC; Barkley RA; Boerwinkle E; Turner ST
BMC Med Genet; 2007 Sep; 8():61. PubMed ID: 17854487
[TBL] [Abstract][Full Text] [Related]
2. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.
Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH
Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011
[TBL] [Abstract][Full Text] [Related]
3. RGS2 expression and aldosterone: renin ratio modulate response to drug therapy in hypertensive patients.
Semplicini A; Strapazzon G; Papparella I; Sartori M; Realdi A; Macchini L; Calò LA; Ceolotto G
J Hypertens; 2010 May; 28(5):1104-8. PubMed ID: 20375904
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients.
Lobmeyer MT; Wang L; Zineh I; Turner ST; Gums JG; Chapman AB; Cooper-DeHoff RM; Beitelshees AL; Bailey KR; Boerwinkle E; Pepine CJ; Johnson JA
Pharmacogenet Genomics; 2011 Jan; 21(1):42-9. PubMed ID: 21127457
[TBL] [Abstract][Full Text] [Related]
5. Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses).
McDonough CW; Magvanjav O; Sá ACC; El Rouby NM; Dave C; Deitchman AN; Kawaguchi-Suzuki M; Mei W; Shen Y; Singh RSP; Solayman M; Bailey KR; Boerwinkle E; Chapman AB; Gums JG; Webb A; Scherer SE; Sadee W; Turner ST; Cooper-DeHoff RM; Gong Y; Johnson JA
Circ Genom Precis Med; 2018 Apr; 11(4):e001854. PubMed ID: 29650764
[TBL] [Abstract][Full Text] [Related]
6. Association and linkage analysis of the alpha-adducin gene and blood pressure.
Bray MS; Li L; Turner ST; Kardia SL; Boerwinkle E
Am J Hypertens; 2000 Jun; 13(6 Pt 1):699-703. PubMed ID: 10912756
[TBL] [Abstract][Full Text] [Related]
7. Interactions between five candidate genes and antihypertensive drug therapy on blood pressure.
Schelleman H; Stricker BH; Verschuren WM; de Boer A; Kroon AA; de Leeuw PW; Kromhout D; Klungel OH
Pharmacogenomics J; 2006; 6(1):22-6. PubMed ID: 16314886
[TBL] [Abstract][Full Text] [Related]
8. Alpha-adducin gene polymorphism and cardiovascular phenotypes in a general population.
Castellano M; Barlassina C; Muiesan ML; Beschi M; Cinelli A; Rossi F; Rizzoni D; Cusi D; Agabiti-Rosei E
J Hypertens; 1997 Dec; 15(12 Pt 2):1707-10. PubMed ID: 9488226
[TBL] [Abstract][Full Text] [Related]
9. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
10. The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study.
Glorioso N; Manunta P; Filigheddu F; Troffa C; Stella P; Barlassina C; Lombardi C; Soro A; Dettori F; Parpaglia PP; Alibrandi MT; Cusi D; Bianchi G
Hypertension; 1999 Oct; 34(4 Pt 1):649-54. PubMed ID: 10523341
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of antihypertensive drug responses.
Schwartz GL; Turner ST
Am J Pharmacogenomics; 2004; 4(3):151-60. PubMed ID: 15174896
[TBL] [Abstract][Full Text] [Related]
13. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects.
O'Shaughnessy KM; Fu B; Dickerson C; Thurston D; Brown MJ
Clin Sci (Lond); 2000 Sep; 99(3):233-8. PubMed ID: 11787477
[TBL] [Abstract][Full Text] [Related]
14. Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 2: clinical studies.
Lanzani C; Citterio L; Glorioso N; Manunta P; Tripodi G; Salvi E; Carpini SD; Ferrandi M; Messaggio E; Staessen JA; Cusi D; Macciardi F; Argiolas G; Valentini G; Ferrari P; Bianchi G
Sci Transl Med; 2010 Nov; 2(59):59ra87. PubMed ID: 21106941
[TBL] [Abstract][Full Text] [Related]
15. [Association of polymorphism in alpha-adducin gene with antihypertensive effect of Hydrochlorothiazide].
Wu SL; Li DQ; Li HF; Yu Q; Li Y; Zhao HY
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Oct; 33(10):880-4. PubMed ID: 16266470
[TBL] [Abstract][Full Text] [Related]
16. NHLBI family blood pressure program: methodology and recruitment in the HyperGEN network. Hypertension genetic epidemiology network.
Williams RR; Rao DC; Ellison RC; Arnett DK; Heiss G; Oberman A; Eckfeldt JH; Leppert MF; Province MA; Mockrin SC; Hunt SC
Ann Epidemiol; 2000 Aug; 10(6):389-400. PubMed ID: 10964005
[TBL] [Abstract][Full Text] [Related]
17. 24-h ambulatory blood pressure is linked to chromosome 18q21-22 and genetic variation of NEDD4L associates with cross-sectional and longitudinal blood pressure in Swedes.
Fava C; von Wowern F; Berglund G; Carlson J; Hedblad B; Rosberg L; Burri P; Almgren P; Melander O
Kidney Int; 2006 Aug; 70(3):562-9. PubMed ID: 16788695
[TBL] [Abstract][Full Text] [Related]
18. Single Agent Antihypertensive Therapy and Orthostatic Blood Pressure Behaviour in Older Adults Using Beat-to-Beat Measurements: The Irish Longitudinal Study on Ageing.
Canney M; O'Connell MD; Murphy CM; O'Leary N; Little MA; O'Seaghdha CM; Kenny RA
PLoS One; 2016; 11(1):e0146156. PubMed ID: 26730962
[TBL] [Abstract][Full Text] [Related]
19. Influence of renin angiotensin system gene polymorphisms on visit-to-visit blood pressure variability in hypertensive patients.
Kawai T; Ohishi M; Onishi M; Takeya Y; Ito N; Kato N; Yamamoto K; Kamide K; Rakugi H
Am J Hypertens; 2012 Dec; 25(12):1249-55. PubMed ID: 22932704
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin -11377C/G and +276G/T polymorphisms affect adiponectin levels but do not modify responsiveness to therapy in resistant hypertension.
de Faria AP; Modolo R; Sabbatini AR; Barbaro NR; Corrêa NB; Brunelli V; Tanus-Santos JE; Fontana V; Moreno H
Basic Clin Pharmacol Toxicol; 2015 Jul; 117(1):65-72. PubMed ID: 25546819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
